Abstract
At the moment, a number of studies have been carried out that have proven that omentin has a sensitizing effect on insulin, has anti-inflammatory and anti-atherosclerotic effects. Plasma levels of omentin are known to be significantly reduced in obese patients with insulin resistance. Decreased levels of omentin have also been reported to be associated with inflammatory and autoimmune diseases, including atherosclerosis and psoriasis. The article presents research data that allow to identify changes in the level of omentin in chronic inflammatory rheumatic diseases, as well as to suggest its effect on the risk of development and course of cardiovascular complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
